Noticias y Actividades de Clover Biopharmaceuticals
Ejecutivos
Ver el organigrama con sus 21 ejecutivos principales
Biografías más buscadas en Clover Biopharmaceuticals
- Joshua Liang, Chief Executive Officer
- Xiaobin Wu, Independent Non-executive Director
- Xiang Liao, Independent Non-executive Director
Recientes movimientos de ejecutivos en Clover Biopharmaceuticals
- Nicholas Jackson, se ha incorporado a la empresa como President, Global Research and Development and Alliances (noticia publicada el 20 de octubre de 2025).
Crear su alerta
para seguir los movimientos de los ejecutivos en Clover Biopharmaceuticals.
Farmacia
Clover Biopharmaceuticals tiene 1.913 competidores entre los que se incluyen Sanofi (Francia), Eli Lilly (Estados Unidos) y Moderna (Estados Unidos).
Popular M&A news in Farmacia
- Contraline acaba de anunciar una recaudación de fondos de 93 millones de dólares. (publicado el 3 de junio de 2026).
- Hims & Hers ha Eucalyptus adquirido (publicado el 2 de junio de 2026).
- Apotex ha presentado su expediente de OPI. Su símbolo de cotización será TSX. (publicado el 2 de junio de 2026).
Otros contactos sugeridos en el sector Farmacia
Noticias
Últimos comunicados de prensa de Clover Biopharmaceuticals
- Clover’s COVID-19 Vaccine Candidate Demonstrates Strong Cross-Neutralization Against Omicron as a Homologous Booster | Clover Biopharmaceuticals, Ltd.
- Clover Doses First Participants in Phase 3 Trial Evaluating SCB-2019 as a Heterologous COVID-19 Booster Following Prior Vaccination with Inactivated, mRNA or Viral Vector Vaccines | Clover Biopharmaceuticals, Ltd.
- Clover Provides Update on 2022 Corporate Milestones | Clover Biopharmaceuticals, Ltd.
- Clover Doses First Participants in Phase 1 Trial with SCB-2020S, a Potentially Broadly Protective Chimeric COVID-19 Vaccine Candidate | Clover Biopharmaceuticals, Ltd.
- Clover’s Bivalent COVID-19 Vaccine Candidate Demonstrates Broad Neutralization Against Omicron and Other Variants of Concern | Clover Biopharmaceuticals, Ltd.
- Clover Appoints LiongHo Chua as President of Greater China | Clover Biopharmaceuticals, Ltd.
- Clover’s COVID-19 Vaccine Candidate Administered as Heterologous Booster in Investigator-Led Phase 2 Clinical Trial - Clover Biopharmaceuticals
- Clover and CEPI Expand Partnership for COVID-19 Vaccine Candidate to Include Evaluation as a Booster - Clover Biopharmaceuticals
- Clover Biopharmaceuticals Announces Offer Price and Allotment Results of the Global Offering - Clover Biopharmaceuticals
- Clover Biopharmaceuticals Completes Enrollment of Adult and Elderly Population in SPECTRA Global Phase 2/3 Clinical Trial for its COVID-19 Vaccine Candidate - Clover Biopharmaceuticals
- View more press releases Close
Redes sociales sobre Clover Biopharmaceuticals
- Clover Biopharmaceuticals en Wikipedia, Google News y Yahoo Finance
- Clover Biopharmaceuticals en LinkedIn, Twitter y YouTube
